A successful case of deceased donor liver transplantation for a patient with intrahepatic arterioportal fistula
Kosei Takagi(Okayama Shoka University), Toshiyoshi Fujiwara(Okayama University), Ryuichi Yoshida(Okayama University), Makiko Tsuboi(Kochi Medical School Hospital), Kenta Sui(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Susumu Shinoura(Okayama University), Nobuyuki Watanabe(Okayama University), Takashi Kuise(Okayama Red Cross General Hospital), Takahito Yagi(Okayama University), Mitsunari Ogasawara(Kochi Medical School Hospital), Akira Hirose(Kochi Medical School Hospital), Shinji Iwasaki(Kochi Medical School Hospital), Toshiji Saibara(Kochi Medical School Hospital), Yuzo Umeda(Okayama University)
Cited by 5
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178